2016
DOI: 10.1016/j.canrad.2015.05.034
|View full text |Cite
|
Sign up to set email alerts
|

Radiothérapie des chloromes ou sarcomes granulocytiques : revue de la littérature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…Concerning treatment strategies, a universal agreement has not yet been established with regard to therapeutic alternatives because of the rarity of the disease and the diversity of body sites and age groups [ 6 , 8 ]. The exclusive local treatments of isolated MS do not seem sufficient, since in the absence of systemic treatment the disease evolves inexorably towards acute leukaemia in 88-100% of cases versus 42% when systemic treatment is delivered to the patient [ 9 ]. In addition, several studies, including those of Tsimberidou et al [ 10 ], Imrie et al [ 11 ], and Cunningham et al [ 12 ] have shown an improvement in the probability of overall survival or survival without progression when a multimodal treatment was offered to the patient (more than 50% of surviving patients for a median follow-up of 25 months per compared to a median survival time of 13 months for untreated patients).…”
Section: Discussionmentioning
confidence: 99%
“…Concerning treatment strategies, a universal agreement has not yet been established with regard to therapeutic alternatives because of the rarity of the disease and the diversity of body sites and age groups [ 6 , 8 ]. The exclusive local treatments of isolated MS do not seem sufficient, since in the absence of systemic treatment the disease evolves inexorably towards acute leukaemia in 88-100% of cases versus 42% when systemic treatment is delivered to the patient [ 9 ]. In addition, several studies, including those of Tsimberidou et al [ 10 ], Imrie et al [ 11 ], and Cunningham et al [ 12 ] have shown an improvement in the probability of overall survival or survival without progression when a multimodal treatment was offered to the patient (more than 50% of surviving patients for a median follow-up of 25 months per compared to a median survival time of 13 months for untreated patients).…”
Section: Discussionmentioning
confidence: 99%
“…Given its low incidence, the therapeutic management of GS is still not consensual. The current management strategies are based on a combination of systemic and local therapies, with a crucial role for RT [2]. …”
Section: Discussionmentioning
confidence: 99%
“…RT results in excellent local disease control and palliation of symptoms without significant toxicity. The recommended RT dose against chloromas is also not consensual, with at least 20 Gy in 10 fractions being most common [2, 6, 7]. …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations